​Volatile Markets? Try Non-Correlated Investments

Anthony Ritossa  |

At a recent meeting of the Ritossa Family Office Summit in Dubai, Jagdeesh Prakasam said something that caught the attention of the several hundred investors who were listening to him.

He said that by using artificial intelligence and machine-based learning, his company has been able to capture some uniquely important inefficiencies in the financial markets. The result?

Achieving Positive Returns in Volatile Markets

The company where Prakasam is Co-Chief Investment Officer, Rotella Capital Management, has been able to achieve positive returns in both up markets and down ones as well.

“In the last 26 years,” Prakasam told his audience, “we’ve had a track record of double digit uncorrelated returns through some of the most challenging market environments. This includes consistent absolute returns during times of crisis for traditional asset classes.”

He went to point to a revealing graph of some of the world financial crises in the last 20 years. Whether it was the Russian Financial Crisis in 1998, or the Dot.Com Bubble of 2002, or the Financial Crisis of 2009, or Brexit in 2016, when the US Stock market tumbled, Rotella’s investments went up.

So, how does he go about finding the non-correlated investments that makes this kind of performance possible?

Rotella’s COO Ian Ram added, “We use a high tech, artificial-intelligence, machine-learning approach to complement our more traditional technical and statistical models. We have 13 research scientists, 10 senior technologists, and 20 other skilled personnel. These individuals include men and women with advanced degrees in physics, engineering, mathematic and financial engineering.”

But that’s only part of his secret sauce. “What we do is an intersection of art and science. The art part is, we begin with intuitive but highly-informed hypotheses and then we test the hypotheses. As part of the testing, we apply sophisticated scientific and mathematical approaches.”

Where Is It All Leading?

When quantitative easing ended in 2014, Prakasam’s colleague, Robert Rotella, knew that among the many implications of ending the six-year $4.5 trillion program, is that the U.S. Government would no longer be supporting the American stock market. This was likely to lead to volatility.

Ending similar liquidity-enhancing programs, whether in Europe or Japan, would also have large implications. After all, when quantitative easing isn’t in effect, it’s typical to have corrections of 10% or 15% in the stock market. Under normal circumstances, these may happen a couple of times a year.

However, during the period from 2008 to 2014, this kind of volatility wasn’t allowed to happen. This meant that for at least six years, investors didn’t have to worry that one of these market drops would happen. They didn’t have to worry about needing liquidity at a time when the market is down.

Today, conditions have changed. Rotella’s premise is that investors who need less volatility need more non-correlated investments. He and his colleagues at Rotella put their enormous intellectual and technical resources into discovering investments that do well independently of the stock market’s roller coaster ride.

Jagdeesh Prakasam was a featured speaker at the Ritossa Family Office 5thGlobal Family Office Investment Summit organized by Anthony Ritossa and held in Dubai.

If you’d like to know more about Rotella Capital Management’s alternative asset approach, contact: investments@rotellacapital.com

Article Authored By Mitzi Perdue, a professional public speaker who talks on family business. Contact her at: mitzi@mitziperdue.com.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.